High-risk human papilloma virus (hrHPV) infections are associated with the development of anogenital cancers, in particular cervical cancer, and a subset of head and neck cancers. Previous studies have shown that microRNAs (miRNAs) contribute to the development and progression of HPV-induced malignancies. miRNAs are small non-coding RNAs that exist as multiple length and sequence variants, termed isomiRs. Efficient processing of miRNAs and generation of isomiRs is accomplished by several processing proteins. Deregulation of Drosha, AGO2, and TENT2, amongst others, has been observed in HPV-induced cancers and was even found at the precancerous stage. This suggests that miRNA processing proteins may be involved during early cancer development and that the generated isomiRs could provide promising biomarkers for early cancer diagnosis.
long miRNA duplex. The name of the miRNA depends on the direction from which the miRNA originates; the 5p strand arises from the 5' end while the 3p arm comes from the 3' end.
One strand of the mature miRNA duplex, the so-called guide strand, assembles into the RNAinduced silencing complex (RISC), where it directly interacts with a member of the Argonaute protein family (AGO), while the so-called passenger strands gets discarded. The classic model predicts that the mature miRNA bound by AGO directs the complex to complementary target mRNAs for transcriptional gene silencing 11 . While most miRNA binding sites are located in the 3' untranslated region (3' UTR) of the target mRNA, other binding sites, i.e. the 5'UTR and the coding sequence, have also been described 12 . The so-called seed sequence of the miRNA -a nucleotide region located at the 5' end of the miRNA (nucleotides 2-8) -is essential for and guides the binding of miRNA to mRNA 13 . Upon binding of RISC, the targeted mRNA can be post-transcriptionally silenced by various mechanisms, depending on the type of AGO protein and the cellular context.
The most prevalent gene silencing mechanism by RISC is translational repression which can be accomplished by inhibition of translational initiation or by target mRNA deadenylation and degradation 14 . Another well-known RISC mechanism is mRNA cleavage. The reading frame of the targeted mRNA is cleaved and degraded by exonucleases. In humans four AGO proteins are known, of which AGO2 is the only AGO protein capable of cleaving targeted mRNAs. In a 2017 study on herpesviruses evidence was provided that miRNAs target mRNAs via binding to virus-encoded small non-coding RNAs 15 . The miRNA in this scenario seems to recruit Argonaute proteins to target mRNAs which is necessary for mRNA repression. With these various RISC mechanisms and the potential of miRNAs to target hundreds of RNA transcripts, individual miRNAs can fine-tune the expression of many genes. The above described miRNA biogenesis pathway is considered the canonical pathway. However, not all miRNAs are processed via the canonical route and several non-canonical miRNA biogenesis pathways have been described, including Drosha-and Dicer-independent pathways 9 . The most well-known non-canonical type of miRNAs are the 'mirtrons' .
Mirtrons originate from introns that bypass Drosha cleavage and, upon splicing, function as pre-miRNAs that can be exported to the cytoplasm by XPO5 and subsequently processed by Dicer for loading into RISC ( Fig. 1 ).
In addition to the aforementioned miRNA processing machinery, several other proteins exist that can influence miRNA processing. Recent advances in small RNA sequencing technology have revealed that a single miRNA can generate numerous length and sequence variants during miRNA processing 16, 17 . These miRNA variants are termed isomiRs and can encompass substitutions, insertions or deletions, 5' and/or 3' cleavage site variations, and terminal nontemplated additions (NTA) 18 . Variations at the cleavage site arise from changes in Drosha and Dicer processing and substitutions by RNA editing enzymes, while terminal NTAs are generated by nucleotidyl transferases (NTases). Alterations in any of the proteins involved in miRNA processing might disturb efficient maturation of precursor miRNAs and/or affect isomiR biogenesis, and could drastically alter miRNA function.
At present, the importance of miRNAs in cancer is well established. By regulating the expression of both oncogenes and tumour suppressor genes they play vital roles in tumourigenesis 7 .
MiRNA expression is both cell-type and tissue-type specific and miRNAs can function either cell autonomously or in a non-cell-autonomous fashion 19 . Their deregulation is often observed in cancer and they serve as powerful biomarkers for cancer diagnosis and prognosis. In addition, a recent study revealed that isomiR profiles can discriminate among 32 cancer types 20 , suggesting that isomiRs provide a novel class of biomarkers. Also, the presence of particular isomiRs might be indicative of an upstream miRNA processing defect, such as genomic mutations, altered expression or changes in the localisation of proteins involved in miRNA maturation and isomiR generation.
Interestingly, viruses have been shown to affect miRNA processing through their viral proteins in order to regulate cellular gene expression 21 . In HPV-induced cancers, many miRNAs have been found to be deregulated, as reviewed by Satapathy et al. 6 , Santos et al. 22 , and Emmett et al. 23 . Furthermore, our recent small RNA sequencing analysis on HPV-positive cervical samples indicated that the isomiR distribution is also disturbed in HPV-induced cancers 24 . This finding, together with the notion that viruses can alter miRNA processes led us to review the current literature on miRNA processing proteins and their alterations during HPV-induced carcinogenesis to obtain further insight in the mechanisms driving miRNA deregulation.
We focus on miRNA processing proteins involved in canonical miRNA processing as well as proteins involved in isomiR biogenesis and only include studies in the context of HPV-mediated transformation. Hence, functional studies performed solely with HeLa cells, high-risk HPV18positive cervical cancer cells, are not addressed in this review. The resulting precursor miRNA (pre-miRNA) is exported from the nucleus to the cytoplasm by XPO5
where it is further cleaved by Dicer in complex with TRBP. One strand of the mature miRNA duplex, together with an AGO protein, is incorporated in RISC and subsequently targets mRNAs for degradation or translational repression. In addition to canonically processed miRNAs, mirtrons originate from introns that, upon splicing, function as pre-miRNAs. IsomiRs are miRNA variants that differ in their length or sequence makeup and can be generated by imprecise cleavage of Drosha and Dicer, nucleotide addition or removal, and RNA editing. Enzymes that are involved in isomiR biogenesis include the RNA editing enzyme ADAR and terminal nucleotidyl transferases (NTases) MTPAP, TENT2, TENT4A, TENT4B, TUT1, TUT4, and TUT7 that can catalyse the addition of either adenine (MTPAP, TENT2, TENT4A, TENT4B) or uridine (TUT4 and TUT7), or both (TUT1) ( Table 1) .
PROTEINS INVOLVED IN CANONICAL MIRNA PROCESSING
Although numerous miRNAs with oncogenic function have been identified, several studies have shown that miRNA expression is globally suppressed in cancer compared to normal cells. This suggests that the miRNA processing machinery might be deregulated in cancer. In fact, HPVinduced cancers often show deregulated expression of Drosha and DGCR8 -key components of the microprocessor.
Drosha is located at chromosome 5p, which is one of the frequently gained chromosomal regions in cervical cancers 25, 26 . It was found that all cervical cancers with 5p gain exhibited Drosha overexpression, indicating that upregulation of Drosha is a copy number driven event 25, 27 . Harden and Munger recently showed that HPV-positive cervical cancer cell lines exhibit higher endogenous levels of Drosha than HPV-negative cervical cancer cells 28 . They further demonstrated that co-expression of HPV16 viral oncogenes E6 and E7, and to a lesser extent expression of the individual genes, can cause overexpression of Drosha in both HPV-negative cervical cancer cells and primary human epithelial cells. Hence, both a gain of chromosome 5p and expression of the two viral oncoproteins E6 and E7 are likely to be involved in the upregulation of Drosha in cervical cancers. These data and the finding that a gain of 5p is also observed in 5-8% of high-grade cervical precancerous lesions 26 suggest that Drosha upregulation may already occur at the precancerous stage. Indeed, analysis of publically available and in-house mRNA expression profiles confirmed an upregulation of Drosha expression in a subset of high-grade cervical precancerous lesions and most cervical cancers ( Fig. 2A and B) 29 .
Enhanced expression of Drosha was found to be associated with altered cancer-associated miRNA profiles and enhanced cell motility and invasiveness 27, 30 . This data supports a role of Drosha as oncogenic driver in cervical cancer. were not significantly associated with OPSCC outcome.
Another key component of the microprocessor, DGCR8, was demonstrated to be upregulated in cervical cancers compared to adjacent normal tissues 32 . Furthermore, the viral oncoprotein E7 was found to upregulate the expression of DGCR8. The elevated levels of DGCR8 subsequently resulted in increased expression of cancer-associated miR-27b, thereby initiating a cascade of events resulting in enhanced proliferation and reduced apoptosis. These findings suggest that DGCR8 is a cancer-promoting factor induced by HPV.
One of the most crucial players in miRNA maturation, Dicer, shows a heterogeneous expression pattern in cervical cancers. He and colleagues revealed that from a set of 90 cervical squamous cell carcinomas (SCC), the majority (63.3%) showed high Dicer mRNA expression compared to adjacent normal cervical epithelium 33 . This expression pattern did not completely reflect Dicer protein levels, since only 49% of SCCs exhibited high Dicer protein expression, indicating that Dicer potentially undergoes post-transcriptional or post-translational regulation. Furthermore, low Dicer mRNA levels were associated with poor disease-free survival, which suggests that Dicer levels could be used as potential prognostic factor in cervical cancer. Conversely, Zhao et al. 34 and Lu et al. 35 , demonstrated an overall downregulation of Dicer mRNA in the majority of cervical cancer tissues compared to normal tissues, but expression levels were rather variable.
This discrepancy between the still limited number of studies may in part relate to differences in histotype and HPV type distributions. Our analysis on publically and in-house available mRNA data confirm a heterogeneous expression pattern of Dicer in cervical cancers ( Fig. 2A and B) 29 .
Harden and Munger showed significantly higher Dicer mRNA levels in HPV16-positive cervical cancer cells compared to HPV-negative cervical cancer cells 28 , indicating that Dicer regulation may be HPV dependent. A potential direct role of HPV16 E6 and E7 in Dicer upregulation is supported by the observed upregulation of Dicer upon ectopic expression of HPV16 E6/E7 in primary human epithelial cells. In contrast, HPV16 E6 has also been demonstrated to negatively regulate the expression of Dicer by inducing degradation of the transcription factor TAp63β, which is involved in Dicer activation 35 .
Overexpression of the tumour suppressive miRNA miR-375 was able to restore TAp63β levels and miR-375 and Dicer expression were found to be positively correlated. Our previous data
show that miR-375 expression is higher in adenocarcinomas than SCC 36 and The Cancer Genome
Atlas (TCGA) data shows that miR-375 levels are higher in HPV18-positive SCC compared to HPV16-positive SCC 37 . Together, this suggests that Dicer levels are higher in HPV18-positive cancers and/or adenocarcinomas. However, studies on Dicer expression in HPV18-positive adenocarcinoma cell lines versus HPV16-positive SCC cell lines report varying findings 28, 35 .
Furthermore, studies on single nucleotide polymorphisms (SNPs) in the Dicer gene showed reduced risk of cervical precancerous lesions 35 , but no association with cervical cancer risk 38 .
Although TRBP plays an important role in miRNA maturation, studies investigating how viral infections or malignant transformation may affect the function of TRBP are lacking.
Another important player in miRNA maturation and major component of RISC, AGO2, was found to exhibit higher mRNA levels in cervical cancer tissues than in the respective adjacent non-cancerous tissues 39 . Besides changes in its expression, AGO2 is a target for regulatory post-translational modifications. Phosphorylation of AGO2 was recently shown to strongly 02 affect mRNA binding while no effect was observed on its capacity to bind miRNAs 40 . While this post-translational modification has been investigated in HeLa cells (HPV18-positive cervical cancer cells), it remains to be determined whether this phenomenon is involved in HPV-induced carcinogenesis.
For many years, Argonaute proteins have been viewed as cytoplasmic proteins. Recent studies, however, have revealed that RNA factors including Argonaute proteins can also be found in cell nuclei 41, 42 . Although the exact functions of nuclear AGO2 are not completely understood, it has been suggested that nuclear AGO2 is involved in DNA repair amongst others 43 . Interestingly, AGO2 was found to be mainly located in the nucleus of primary human foreskin keratinocytes while cervical cancer cells exhibited mostly cytoplasmic AGO2 expression and only a minor expression in their nuclei 43 . Infection of primary keratinocytes with HPV16 or HPV18 did not influence AGO2 nuclear distribution, both when grown in monolayers and in organotypic cultures. Similar to primary keratinocytes, also in normal cervical epithelium AGO2 was primarily found in the nucleus 43 . However, in contrast to cervical cancer cell lines, AGO2 mainly displays as a nuclear protein in cervical cancer tissues 43 . This indicates that the subcellular distribution of AGO2 can be cell type-and tissue context-dependent, and may change with cancer development.
PROTEINS INVOLVED IN ISOMIR BIOGENESIS
Besides their function in miRNA biogenesis, some of the above mentioned miRNA processing proteins are also involved in the generation of miRNA variants, so-called isomiRs. IsomiRs originate from a single miRNA locus but can differ in their length and sequence makeup 16 .
Imprecise cleavage of Drosha or Dicer can result in length differences at both the 3' and 5' end of the sequence. In this case, the isomiR sequence matches those of the miRNA gene but differs in length. These isomiRs are referred to as 'templated' . Terminal end sequence differences that do not match the miRNA gene are called 'non-templated' . Non-templated isomiRs can arise from 1) post-transcriptional addition of one or more nucleotides at the 5' or 3' end by NTases, or 2)
RNA-editing enzymes that alter internal nucleotides. The latter are referred to as polymorphic isomiRs.
Polymorphic isomiRs are generated by RNA-editing enzymes such as adenosine deaminase acting on RNA (ADAR) 44 . ADARs convert adenosine (A) to inosine (I) in double-stranded RNAs.
Primary miRNAs as well as precursor and mature miRNAs are known to undergo A-to-I editing, which affects miRNA maturation and activity 45, 46 . For example, pri-miR-142 is highly edited by ADAR1 and/or ADAR2 and this editing results in inhibition of Drosha cleavage and thereby reduces the expression of miR-142 47 . Also, A-to-I editing of miR-376 was shown to occur in the seed region of miR-376, altering its target profile 48 .
Despite their importance in miRNA processing and function, only a few studies on ADAR in HPVinduced cancers have been reported. ADAR1 mRNA was found to be highly expressed in cervical cancer tissues, while relatively low levels of ADAR1 in precancerous lesions and no expression in normal cervix were observed 49 . Moreover, cervical cancer patients that exhibited high ADAR1 expression had a lower overall survival compared to patients with low ADAR1 levels. Similar to those findings, results from a different study showed that mRNA levels of ADAR1 as well as ADAR2 are higher in cervical cancer tissues compared to the respective adjacent non-cancerous tissue 50 . These results indicate that ADARs are potentially involved in cervical carcinogenesis.
In recent years, several enzymes have been linked to isomiR biogenesis. These enzymes include terminal NTases MTPAP, TENT2 (PAPD4), TENT4A (PAPD7), TENT4B (PAPD5), TUT1, TUT4 (ZCCHC11), and TUT7 (ZCCHC6) 51 . Most enzymes have multiple gene names, which can create some confusion as to their precise functioning (Table 1 ). In this article, we will use their HUGOapproved nomenclature, as was recently proposed by Menezes et al. 52 .
NTases are template-independent polymerases that add ribonucleotides to the end of RNA molecules 53 . They can possess either adenylation (addition of an adenine) or uridylation (addition of a uridine) activity, or both. Uridylation of miRNAs does not only create isomiRs but has also been shown to regulate miRNA biogenesis 52 . Most pre-miRNAs have a 2 nucleotide 3' overhang upon Drosha cleavage that is recognised in the cytoplasm by Dicer (group I). However, some pre-miRNAs contain a single uridine at their 3'end (group II). These group II miRNAs include most let-7 family members as well as miR-105. Monouridylation -addition of one uridine -of these pre-miRNAs is needed in order to establish efficient Dicer processing and has been reported to be accomplished by TUT4 and TUT7 54 . In addition to monouridylation, polyuridylation -addition of multiple uridines -is also involved in miRNA biogenesis. TUT4 was shown to add a polyUtail to pre-let-7 which blocks Dicer cleavage 55 . The polyU-tail of pre-let-7 was subsequently recognised by exonuclease Dis3L2 and resulted in pre-let-7 degradation 56 .
At present the role of NTases in cancer remains largely unexplored. To the best of our knowledge, only one study reports on NTases in HPV-induced cancers. In a study on factors that regulate E6 expression in cervical carcinogenesis it was found that the NTase TUT1 (referred to as star-PAP) controls E6 polyadenylation and thereby its expression in cervical cancer cells 57 .
Moreover, when TUT1 expression was reduced, cervical cancer cells became more sensitive to chemotherapeutic treatment. This indicates that TUT1 could serve as a potential drug target for the treatment of cervical cancer.
Since data on proteins involved in isomiR biogenesis in cervical cancer is limited, we used in-house available microarray mRNA profiles of cervical tissues to analyse their expression pattern in normal cervical epithelium, high-grade precancerous lesions (referred to as cervical intraepithelial neoplasia (CIN)), and cervical SCC. We observed significantly higher expression levels of Drosha, XPO5, AGO2, ADAR, and TENT2 in SCC compared to high-grade CIN and/ or normal cervical tissues (Fig. 2B ). The expression of TUT7 was significantly reduced with severity of cervical disease. For Drosha and Dicer, a similar expression pattern was observed in a publically available dataset of cervical tissues consisting of normal, low-and high-grade CIN, and cervical cancer ( Fig. 2A) 29 .
Additionally we analysed The Cancer Genome Atlas (TCGA) database (243 SCCs) 37 for genomic and expression alterations of miRNA processing proteins in cervical cancer. Most genomic alterations are found for Drosha (7%) and TENT4A (6%) and mainly include amplifications ( Fig. 3A) . Both genes are located on chromosome 5p, which is gained in many cervical cancers.
Consistently, a gain of 5p is often accompanied by increased mRNA levels of Drosha and TENT4A (Fig. 3B) . Additionally, putative driver mutations were seen in Dicer (n=3; Fig. 3A ).
In general, genomic alterations seem to coincide with altered mRNA expression levels, which are prominently seen for Drosha and TENT4A, but also for Dicer and ADAR1 (Fig. 3A and B) .
Moreover, TCGA data shows that SCCs harbouring a 5p gain exhibit increased Drosha mRNA levels (Fig. 3B) , which is in line with previous findings 25, 27 . The above summarised findings indicate that miRNA processing proteins Drosha, DGCR8, Dicer, and AGO2 are deregulated in HPV-induced cancers. Furthermore, the viral oncoproteins E6 and E7 have been implicated in Drosha, DGCR8, and Dicer regulation, but the exact role of HPV on miRNA processing proteins needs to be further elucidated.
Despite a lack of studies focusing on NTases involved in isomiR generation in respect to HPVinduced cancers, data from TCGA and in-house studies indicate that several NTases such as TENT2 and TENT4A are altered in cervical cancer or even at the precancerous stage. This indicates that NTases are likely to be involved during the early steps of cancer development.
Since alterations of NTase levels directly affect isomiR biogenesis, the generated isomiRs could provide promising biomarkers for early cancer diagnosis. Future studies are needed to elucidate the exact role of NTases during carcinogenesis and their modulation might provide a potential therapeutic avenue.
